- Home
- BA vs NVS Comparison
BA vs NVS Comparison
Compare BA & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BA | NVS |
|---|---|---|
| Founded | 1916 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.2B | 286.5B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | BA | NVS |
|---|---|---|
| Price | $219.99 | $153.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 5 |
| Target Price | ★ $269.75 | $144.00 |
| AVG Volume (30 Days) | ★ 5.9M | 1.7M |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | ★ 113.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,463,000,000.00 | N/A |
| Revenue This Year | $12.16 | $2.30 |
| Revenue Next Year | $14.78 | $5.27 |
| P/E Ratio | ★ N/A | $23.13 |
| Revenue Growth | ★ 34.50 | N/A |
| 52 Week Low | $176.77 | $112.34 |
| 52 Week High | $254.35 | $170.46 |
Technical Indicators
Market Signals| Indicator | BA | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 57.83 |
| Support Level | $211.89 | $143.27 |
| Resistance Level | $228.58 | $154.57 |
| Average True Range (ATR) | 6.19 | 2.32 |
| MACD | 0.16 | 0.38 |
| Stochastic Oscillator | 49.42 | 86.70 |
Price Performance
Historical ComparisonAbout BA Boeing Company (The)
Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.